Navigation Links
Nucletron Announces 2008 Results
Date:4/24/2009

VEENENDAAL, The Netherlands, April 24 /PRNewswire/ --

- Strong Product Offerings and Leadership in Brachytherapy Contribute to All-Time High

Nucletron, a global leader in radiation oncology, today announced strong financial results in 2008 with net sales of EUR112.4 million (US $165 million). EBITDA in 2008 ended at an all time high (in constant currencies) of EUR17 million with a strong fourth quarter contributing significantly to the year-end success. Despite challenging global economic conditions, Nucletron surpassed projections in 2008 due in large part to a renewed focus on brachytherapy treatment and an expanding product offering in external beam treatment planning software solutions.

Among the several advancements announced in 2008 was the introduction on Oncentra(R) Brachy, a new comprehensive volume-based treatment planning solution that optimizes cancer treatment planning with brachytherapy. Additionally, Oncentra(R) RT Viewer received clearance in 2008. Oncentra RT Viewer enables clinicians to review radiotherapy plans generated with a wide variety of DICOM-compliant treatment planning systems in a Windows (PC) environment.

"In the second half of 2008, we improved our focus on innovation and marketing efforts, while strengthening our management team. Given our many upcoming product releases in the months to come, we are on track to achieve our 2009 goals as planned," said Jos Lamers, chief executive officer of Nucletron.

About Nucletron

Nucletron is a global leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditi
'/>"/>

SOURCE Nucletron B V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
2. Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
3. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
4. Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
5. OmniComm Systems Announces 1st Quarter Results of Operations
6. Medivation Announces Upcoming Scientific Presentations at Medical Conferences
7. China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results
8. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
9. Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm
10. Metabolex Announces Election of Kurt von Emster to Board of Directors
11. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Protocol Networks brings independent technology ... of brand-neutral, independent consultants, Protocol Networks has recently announced ... over the years, his company has attracted several clients ... Plainfield, as well as others. With the success of ...
(Date:1/22/2015)... MA (PRWEB) January 22, 2015 zFlo ... is pleased to announce an exciting product from a new ... motion analysis solutions over the past 15 years, with offerings ... Most recently, their 3D IMU system (inertial measurement unit), iSen, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, ... Sequenom, Inc. (NASDAQ: SQNM ), the ... agreement for next generation noninvasive prenatal tests (NIPT). ... interpretation technology, called Mantis™, to advance analysis of ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 23D Motion Capture Just Got Easy 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... JERUSALEM, Israel , May 6, 2010 ... delivery,systems, reported today results for the recently completed Phase 2b non-FDA,clinical ... , , ... randomized, double-blind, placebo-controlled, multi-centered study,conducted in South Africa evaluated ...
... 6 Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ... webcast discussing the Company,s 2010 first quarter financial results on ... Michael T. Flavin , Ph.D., Chairman & Chief Executive Officer, ... present an update on the Company. A press release reporting the ...
... consist of three main parts: endosperm, bran and germ. In ... based on kernels or flour after removal of bran and ... and other bioactive components. In the past decade consumers have ... of whole grain products is growing world wide and in ...
Cached Biology Technology:Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 2Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 3Advanced Life Sciences to Host 2010 First Quarter Financial Results Conference Call and Webcast 2The European HEALTHGRAIN consortium developed a definition for whole grain 2
(Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and ... the addition of the "Global Wearable Technologies ... Growth, Share, Overview, Trends and Forecast 2014-2020" ... Wearable Technologies are smart devices that can be ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ... "The Global Watermarking and Fingerprinting Markets" report ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides an ... fingerprinting markets. Watermarking aims to control and monitor ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2
... revealed what may well be the first pervasive rule ... the Proceedings of the National Academy of Sciences researchers ... to become increasingly more complex. Looking back ... catalogue to the present day, the team investigated the ...
... not only smart, but they also wage a good ... studies have shown that plants can sense attacks by ... been known what happens between the pathogen attacks and ... revealed a very complex process that explains how plants ...
... holds three patents in the emerging field of nanotechnology ... the technology,s potential in materials science and medicine. ... a strong call for exploring potential environmental and health ... designing new materials with reduced hazard. The available data, ...
Cached Biology News:First 'rule' of evolution suggests that life is destined to become more complex 2Researcher discovers pathway plants use to fight back against pathogens 2Think green, UO's Hutchison says, to reduce nanotech hazards 2Think green, UO's Hutchison says, to reduce nanotech hazards 3